BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carvajal-Vidal P, Mallandrich M, García ML, Calpena AC. Effect of Different Skin Penetration Promoters in Halobetasol Propionate Permeation and Retention in Human Skin. Int J Mol Sci 2017;18:E2475. [PMID: 29160818 DOI: 10.3390/ijms18112475] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Liu C, Jia W, Xu W, Quan P, Fang L. The Molecular Mechanism of Propylene Glycol Monocaprylate on Skin Retention: Probing the Dual Roles on the Molecular Mobility and Collagen Connection in Roflumilast Cream. AAPS PharmSciTech 2022;23:136. [PMID: 35534759 DOI: 10.1208/s12249-022-02284-y] [Reference Citation Analysis]
2 Espinoza LC, Sosa L, Granda PC, Bozal N, Díaz-Garrido N, Chulca-Torres B, Calpena AC. Development of a Topical Amphotericin B and Bursera graveolens Essential Oil-Loaded Gel for the Treatment of Dermal Candidiasis. Pharmaceuticals (Basel) 2021;14:1033. [PMID: 34681257 DOI: 10.3390/ph14101033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Phan TL, Hieu NV, Li TS, Tsao KC, Ching CTS. Noninvasive and real-time in vivo characterization of Inflammation skin. A feasibility of animal study. Skin Res Technol 2021. [PMID: 33890700 DOI: 10.1111/srt.13030] [Reference Citation Analysis]
4 Carvajal-Vidal P, González-Pizarro R, Araya C, Espina M, Halbaut L, Gómez de Aranda I, García ML, Calpena AC. Nanostructured lipid carriers loaded with Halobetasol propionate for topical treatment of inflammation: Development, characterization, biopharmaceutical behavior and therapeutic efficacy of gel dosage forms. Int J Pharm 2020;585:119480. [PMID: 32479897 DOI: 10.1016/j.ijpharm.2020.119480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Carvajal-Vidal P, Fábrega MJ, Espina M, Calpena AC, García ML. Development of Halobetasol-loaded nanostructured lipid carrier for dermal administration: Optimization, physicochemical and biopharmaceutical behavior, and therapeutic efficacy. Nanomedicine 2019;20:102026. [PMID: 31170512 DOI: 10.1016/j.nano.2019.102026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
6 Yu CH, Suh B, Shin I, Kim EH, Kim D, Shin YJ, Chang SY, Baek SH, Kim H, Bae ON. Inhibitory Effects of a Novel Chrysin-Derivative, CPD 6, on Acute and Chronic Skin Inflammation. Int J Mol Sci 2019;20:E2607. [PMID: 31141897 DOI: 10.3390/ijms20112607] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
7 Rincón M, Calpena AC, Fabrega MJ, Garduño-Ramírez ML, Espina M, Rodríguez-Lagunas MJ, García ML, Abrego G. Development of Pranoprofen Loaded Nanostructured Lipid Carriers to Improve Its Release and Therapeutic Efficacy in Skin Inflammatory Disorders. Nanomaterials (Basel) 2018;8:E1022. [PMID: 30544628 DOI: 10.3390/nano8121022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Gonzalez-pizarro R, Silva-abreu M, Calpena AC, Egea MA, Espina M, García ML. Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye. International Journal of Pharmaceutics 2018;547:338-46. [DOI: 10.1016/j.ijpharm.2018.05.050] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]